Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ishraq Dhaifalah"'
Publikováno v:
Biomedical Papers, Vol 163, Iss 3, Pp 265-268 (2019)
Aim: The aim of this study was to determine the prevalence of maternal hypothyroidism in the first trimester from 11 to 14 weeks of gestation according to the American Thyroid Association (ATA) guidelines from 2017 and to compare the rates for single
Externí odkaz:
https://doaj.org/article/acf8f5f84b504f59ad54bf0a161eacfc
Publikováno v:
Journal of Fetal Medicine. :123-126
The objective of this study was to follow up women with positive results on routine antenatal screening for maternal thyroid disease. Between November 2009 and September 2015, women having a first trimester Down’s syndrome screening test were simul
Publikováno v:
Prenatal Diagnosis. 37:510-514
Objective The article aimed to assess the benefit of incorporating maternal serum thyroid disease marker levels (thyroid-stimulating hormone and free thyroxine) into first trimester Down syndrome screening protocols. Methods Statistical modelling was
Publikováno v:
Biomedical Papers, Vol 163, Iss 3, Pp 265-268 (2019)
Aim: The aim of this study was to determine the prevalence of maternal hypothyroidism in the first trimester from 11 to 14 weeks of gestation according to the American Thyroid Association (ATA) guidelines from 2017 and to compare the rates for single
Autor:
I. Holuskova, Radek Vrtel, Katherine Vomackova, Marian Kacerovsky, V. Durdova, Radek Vodicka, Maria Janikova, Hana Filipova, Martin Prochazka, Romana Kratochvilova, Ladislav Dušek, M. Studnickova, Ishraq Dhaifalah, Tereza Dolezalová, Eva Krejcirikova, Marek Lubusky, Jana Bohmova
Publikováno v:
Fetal Diagnosis and Therapy. 40:48-53
Background: The clinical importance of assessing the fetal KEL genotype is to exclude ‘K'-positive fetuses (genotype KEL1/KEL2) in ‘K'-alloimmunized pregnant women (genotype KEL2/KEL2). Noninvasive assessment of the fetal KEL genotype is not yet
Publikováno v:
Prenatal diagnosis. 37(5)
The article aimed to assess the benefit of incorporating maternal serum thyroid disease marker levels (thyroid-stimulating hormone and free thyroxine) into first trimester Down syndrome screening protocols.Statistical modelling was used to predict pe
Publikováno v:
Journal of Clinical Laboratory Analysis. 32:e22405
BACKGROUND: To establish maternal thyroid‐stimulating hormone (TSH) reference ranges for first trimester screening from 11 + 0 to 13 + 6 weeks of gestation. METHODS: A total of 10 592 singleton and 201 twin consecutive Caucasian pregnant women who
Autor:
Ivana Mickova, Ishraq Dhaifalah, Martin Prochazka, Marek Lubusky, Jiri Santavy, Jiri Hyjanek, Katherine Vomackova
Publikováno v:
Prenatal Diagnosis. 27:327-331
Objectives To determine the possible association between single umbilical artery (SUA) in the second trimester of pregnancy and the incidence of chromosomal abnormalities. To determine whether the presence of chromosomal defects in fetuses with SUA i
Autor:
Jana, Böhmova, Radek, Vodicka, Marek, Lubusky, Iva, Holuskova, Martina, Studnickova, Romana, Kratochvilova, Eva, Krejcirikova, Maria, Janikova, Veronika, Durdová, Tereza, Dolezalová, Hana, Filipová, Ladislav, Dusek, Ishraq, Dhaifalah, Katherine, Vomackova, Marian, Kacerovsky, Martin, Prochazka, Radek, Vrtel
Publikováno v:
Fetal diagnosis and therapy. 40(1)
The clinical importance of assessing the fetal KEL genotype is to exclude 'K'-positive fetuses (genotype KEL1/KEL2) in 'K'-alloimmunized pregnant women (genotype KEL2/KEL2). Noninvasive assessment of the fetal KEL genotype is not yet available in the
Publikováno v:
Biomedical Papers. 150:279-283
Background About 20 percent of the population in developing countries is composed of women of reproductive age. These women face one of the catastrophic risks of pregnancy "uterine rupture". Studies conducted in the developing world give strong evide